|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:awards
|
gptkb:National_Technology_Award_(India)
|
|
gptkbp:businessModel
|
private
|
|
gptkbp:CEO
|
gptkb:Krishna_Ella
|
|
gptkbp:collaboratedWith
|
gptkb:National_Institute_of_Virology
gptkb:Indian_Council_of_Medical_Research
|
|
gptkbp:country
|
gptkb:India
|
|
gptkbp:focus
|
vaccines
research and development
biopharmaceuticals
|
|
gptkbp:foundedBy
|
gptkb:Krishna_Ella
gptkb:Suchitra_Ella
|
|
gptkbp:foundedIn
|
1996
|
|
gptkbp:headquartersLocation
|
gptkb:Hyderabad
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bharat Biotech
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:notableWork
|
COVID-19 vaccine development
|
|
gptkbp:numberOfEmployees
|
over 1600
|
|
gptkbp:product
|
gptkb:Covaxin
gptkb:BioPolio
gptkb:Chikungunya_vaccine_(under_development)
gptkb:JENVAC
gptkb:Rotavac
gptkb:Typbar_TCV
|
|
gptkbp:regulates
|
Covaxin approved for emergency use in India
|
|
gptkbp:servesArea
|
worldwide
|
|
gptkbp:subsidiary
|
gptkb:Chiron_Behring_Vaccines
|
|
gptkbp:website
|
https://www.bharatbiotech.com/
|
|
gptkbp:bfsParent
|
gptkb:Covaxin
|
|
gptkbp:bfsLayer
|
5
|